Form 4 for SKIN SkinHealth Systems Inc.
Accepted 2021-07-19 00:00:00 ET · period of report 2021-07-15 · accession 0001818093-21-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-19 | 2021-07-15 | SKIN | Woo Liyuan | CFO | J - Other | $0.00 | +77.1K | 346.6K | +29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-07-15 | J | A | 77,105 | $0.00 | 346,607 | D | — | — | (F1) The reported acquisition reflects earnout shares issued pursuant that certain Agreement and Plan of Merger, dated as of December 8, 2020, by and among Vesper Health Acquisition Corp, Hydrate Merger Sub I, Hydrate Merger Sub II LLC, LCP Edge Intermediate, Inc. the indirect parent of Edge Systems LLC d/b/a the HydraFacial Company and LCP Edge Holdco, LLC. |